ÂÜÀòÂÒÂ×

Carla Emordi-Fiankan is an accomplished regulatory affairs leader with extensive experience in the biopharmaceutical industry. Currently serving as Vice President of Regulatory Affairs at InterMune, Inc. since August 2011, Carla Emordi-Fiankan specializes in regulatory strategy, clinical development, product life-cycle management, and global branding. Prior to this, Carla Emordi-Fiankan held the position of Senior Director of Regulatory CMC at InterMune, focusing on regulatory strategy and product management. At Gilead Sciences, Inc., from April 2003 to December 2010, Carla Emordi-Fiankan managed the Regulatory Affairs group for small molecules and sterile products, contributing as a core member of various internal teams. Earlier experience includes a role at Amgen Inc. where Carla Emordi-Fiankan was a primary US regulatory representative and played a key role in negotiating FDA approvals, achieving significant corporate savings. Carla Emordi-Fiankan's career began in regulatory affairs at InSite Vision, Inc. and is supported by a BSc in Biology from Notre Dame de Namur University and graduate work in Microbiology from San Jose State University.